Left Atrial Appendage (LAA) Occluders

This channel includes news and new technology innovations about Left Atrial Appendage (LAA) Occluders. These close off the LAA in patients with atrial fibrillation to prevent the formation of stroke-causing clots than embolize to brain.

The Watchman device is a transcatheter left atrial appendage occluder. It is meant to be an alternative to blood thinners in preventing stroke in patients with atrial fibrillation.

Feature | September 07, 2010 | John Kao, M.D., FACC and Anupama Shivaraju, M.D.

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is a major risk factor for developing...

News | June 17, 2010

June 17, 2010 – AGA Medical Holdings Inc. this week announced first patient enrollment in the feasibility...

Technology | June 16, 2010

June 16, 2010 – A new surgical device for excluding the left atrial appendage has received clearance from...

News | March 25, 2010

March 25, 2010 – The FDA this week granted permission for a conditional investigational device exemption (...

LARIAT Suture Delivery Device

News | August 23, 2009

August 24, 2009 – Physicians at The Mount Sinai Medical Center were the first in the country to perform a...

News | May 11, 2009

May 11, 2009 - Medtronic Inc. today announced the successful implant of its Cardioblate Closure Left Atrial...

Feature | April 02, 2009

April 2, 2009 - A device implanted in the heart using minimally invasive techniques may replace the most...

News | March 06, 2009

March 6, 2009 - Atritech Inc. will release PROTECT AF trial results on WATCHMAN LAA closure technology...

News | August 18, 2008

August 18, 2008 - Atritech Inc. today said it filed its pre-market approval application (PMA) with the FDA...

Technology | May 08, 2007

The Watchman device is designed to keep harmful sized blood clots that form in the left atrial appendage...

Overlay Init